SYRE
Spyre Therapeutics Inc.
Company Overview
| Mkt Cap | $959.77M | Price | $24.46 |
| Volume | 683.32K | Change | +0.82% |
| P/E Ratio | -4.6 | Open | $24.10 |
| Revenue | -- | Prev Close | $24.26 |
| Net Income | $-208.0M | 52W Range | $10.91 - $40.26 |
| Div Yield | N/A | Target | $52.91 |
| Overall | 52 | Value | 60 |
| Quality | 31 | Technical | 66 |
No chart data available
Stock Overview
Updated DailySpyre Therapeutics Inc. (SYRE) is a leading diversified company in the business industry, currently trading at $24.46 with a market capitalization of $959.77 million. The stock is trading in the middle of its 52-week range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows SYRE with a volume of 683K shares. The stock opened down 0.66% from yesterday's close of $24.26. Current analyst estimates project earnings of $-2.6 per share for this year, with next year targeting $-3.06.
SYRE demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange.
Key investment considerations for SYRE include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 116.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 02:03 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SYRE | $24.46 | +0.8% | 683.32K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |